Impax Asset Management Group PLC Insulet Corp Transaction History

Impax Asset Management Group PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	SELL	$127.77 - $221.42 $27,598 - $47,826	-216 Reduced 12.96%	1,451 $314,000
Q3 2023 Nov 07, 2023	SELL	$154.67 - $290.89 $4,485 - $8,435	-29 Reduced 1.71%	1,667 $265,000
Q2 2023 Aug 07, 2023	BUY	$272.48 - $330.23 $28,610 - $34,674	105 Added 6.6%	1,696 $489,000
Q1 2023 May 10, 2023	SELL	$276.36 - $326.03 $36,479 - $43,035	-132 Reduced 7.66%	1,591 $507,000
Q4 2022 Feb 09, 2023	SELL	$212.22 - $313.46 $134,759 - $199,047	-635 Reduced 26.93%	1,723 $507,000
Q3 2022 Nov 08, 2022	BUY	$224.6 - $281.45 $60,642 - $75,991	270 Added 12.93%	2,358 $541,000
Q2 2022 Aug 11, 2022	SELL	$186.4 - $279.02 $83,880 - $125,558	-450 Reduced 17.73%	2,088 $455,000
Q1 2022 May 16, 2022	BUY	$194.8 - $275.7 $779 - $1,102	4 Added 0.16%	2,538 $676,000
Q4 2021 Feb 14, 2022	BUY	$255.32 - $318.29 $110,553 - $137,819	433 Added 20.61%	2,534 $674,000
Q1 2021 May 14, 2021	BUY	$235.95 - $293.05 $4,483 - $5,567	19 Added 0.91%	2,101 $548,000
Q4 2020 Feb 16, 2021	BUY	$215.97 - $265.89 $449,649 - $553,582	2,082 New	2,082 $532,000

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.4B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

Stay updated on Impax Asset Management Group PLC with notifications on news.